4.0
Feb 10, 2013
Anonymous employee
Former employee
Recommend
CEO approval
Business Outlook
Pros
the company had good benefits and competitive salaries, assignments allowed opportunities for further growth. For its size, the company had a decent revenue stream. good place to start your career and to learn
Cons
the company had its ups and downs the most recent one from losing a key product in Vytorin due to a small clinical trial. CEO Fred Hassan ended-up selling the company at the great bottom of the financial crisis to another behemoth company.